PharmaShots | Incisive News in 3 Shots

Subscribe Now

Triple-Negative

Roche's Ventana PD-L1 (SP142) Receives FDA's Approval for Identifying Triple-Negative Breast Cancer (TNBC) as CDx

Roche's Ventana PD-L1 (SP142) Receives FDA's Approval for Identifying Triple-Negative Breast Cancer (TNBC) as CDx

March 11, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us